Once the cancer has arisen, AMPK can switch to being a tumour promoter by enhancing cancer cell survival under various upstream metabolic, genotoxic or oxidative stresses (Vara-Ciruelos et al., 2019). The gene discussed is PRKAA2; the disease is neoplasm.